Startups
DelveInsight Business Research LLP
Edit

DelveInsight Business Research LLP

Trusted
https://www.delveinsight.com/?utm_source=cision&utm_medium=pressrelease&utm_campaign=ppr
Last activity: 18.05.2026
Active
Categories: AnalyticsAssistedBioTechBusinessDrugFirmIndustryMarketMedtechResearch
DelveInsight is a cutting-edge market and pipeline analysis and API intelligence knowledge partner for the Pharma and Biotech sector, helping clients to quantify market events and evaluate their impact on the valuation of products, portfolios and companies.

We combine industry expertise with innovation by collecting, analyzing and communicating to deliver critical information to leading decision makers in the Approved drugs market, Active Pharmaceutical (API) market, Generic market and Drug’s research and development. We help Drug developing companies, Generics and API manufacturing companies to strategize and identify the right thrust areas and potential customers for their existing and new products.

The pharmaceuticals market is in its growth stage and we are uniquely positioned to successfully endeavor the dimensions of the fast growing market by providing cutting-edge market and pipeline information, to our clients.

Linkedin: https://www.linkedin.com/company/delveinsight-business-research-llp
Likes
346
Followers
213
Followers
3.53K
Website visits
28.4K /mo.
Mentions
962

Overview

Location
India, Delhi, New Delhi
Employees
51-200
Phone
+1 919-321-6187
Founded date
2014

Mentions in press and media 962

DateTitleDescription
Sign up to seeSign up to seeSign up to see
Mar 27, 2026Verigraft's P-TEV: Advancing Personalized Regenerative Therapy for CVIVerigraft launches pivotal Phase II/III trials for P-TEV, a personalized biological therapy. It targets Chronic Venous Insufficiency (CVI), a widespread vascular disease lacking curative treatment. P-TEV replaces diseased veins, ending life...
Mar 25, 2026VERIGRAFT Advances First Potential Curative Treatment for CVI into Pivotal Phase II/III TrialPivotal Phase II/III clinical trial underway, aiming for US and European market approval in 2028 A 'truly transformative' regenerative medicine targeting a multi-million patient population with no existing curative treatment Fully biologica...
Feb 18, 2025Gastroesophageal Reflux Disease Market Predicted to See Upsurge Through 2034, Highlights DelveInsightGastroesophageal Reflux Disease Market Insights DelveInsight’s Gastroesophageal Reflux Disease Market report offers an in-depth understanding of the epidemiology and market trends in the 7MM. LAS VEGAS, NV, UNITED STATES, February 18, 2025 ...
Feb 18, 2025Heparin Induced Thrombocytopenia Market Set to Grow Substantially Through 2034, DelveInsight ProjectsHeparin-induced Thrombocytopenia Market Forecast DelveInsight’s Heparin Induced Thrombocytopenia Market report offers an in-depth understanding of the epidemiology and market trends in the 7MM. LAS VEGAS, NV, UNITED STATES, February 18, 202...
Feb 18, 2025Glaucoma Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight ReportsGlaucoma Market Trends DelveInsight’s Glaucoma Market report offers an in-depth understanding of the epidemiology and market trends in the 7MM. LAS VEGAS, NV, UNITED STATES, February 18, 2025 /EINPresswire.com/ -- DelveInsight’s “Glaucoma M...
Feb 18, 2025Gastric Neuroendocrine Tumors Market Expected to Experience Major Growth by 2032, According to DelveInsightGastric Neuroendocrine Tumors Market Forecast DelveInsight’s Gastric Neuroendocrine Tumors Market report offers an in-depth understanding of the epidemiology and market trends in the 7MM. LAS VEGAS, NV, UNITED STATES, February 18, 2025 /EIN...
Feb 12, 2025Peripheral T-cell Lymphoma Clinical Trials:- EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, CompaniesPeripheral T-cell Lymphoma Pipeline Peripheral T-cell Lymphoma Pipeline LAS VEGAS, NV, UNITED STATES, February 12, 2025 /EINPresswire.com/ -- DelveInsight’s, “Peripheral T-cell Lymphoma Pipeline Insight” report provides comprehensive insigh...
Feb 12, 2025Cytokine Release Syndrome Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, INDCytokine Release Syndrome Pipeline Cytokine Release Syndrome Pipeline LAS VEGAS, NV, UNITED STATES, February 12, 2025 /EINPresswire.com/ -- DelveInsight’s, “Cytokine Release Syndrome Pipeline Insight” report provides comprehensive insights ...
Feb 12, 2025STAT Inhibitors Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and CompaniesSTAT Inhibitors Pipeline STAT Inhibitors Pipeline LAS VEGAS, NV, UNITED STATES, February 12, 2025 /EINPresswire.com/ -- DelveInsight’s, “STAT Inhibitors Pipeline Insight” report provides comprehensive insights about 20+ companies and 25+ pi...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In

FAQ about DelveInsight Business Research LLP

When was DelveInsight Business Research LLP founded?

DelveInsight Business Research LLP was founded in 2014.

What has the press written about DelveInsight Business Research LLP?

Parsers VC has collected 962 articles mentioning DelveInsight Business Research LLP, among them “Verigraft's P-TEV: Advancing Personalized Regenerative Therapy for CVI” (Mar 27, 2026) and “VERIGRAFT Advances First Potential Curative Treatment for CVI into Pivotal Phase II/III Trial” (Mar 25, 2026).

Is DelveInsight Business Research LLP still active?

Yes, DelveInsight Business Research LLP is active; its latest activity on Parsers VC dates from May 18, 2026.